SEC Company Response from TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Oct 14, 2008
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: Oct. 14, 2008 · CIK: 0000818686 · Accession: 0000950123-08-012825
AI Filing Summary & Sentiment
File numbers found in text: 333-153497
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Teva Pharmaceutical Industries Limited
5 Basel Street
P.O. Box 3190
Petach Tikva 49131
Israel
VIA EDGAR AND FACSIMILE
October 14, 2008
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attention: Mr. Jeffrey Riedler, Assistant Director
Re:
Registration Statement on Form F-4 (File No. 333-153497)
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Teva Pharmaceutical Industries
Limited (the “Registrant”) hereby requests that the effective date of its above-referenced
Registration Statement on Form F-4 initially filed with the Securities and Exchange Commission (the
“Commission”) on September 16, 2008, as amended (the “Registration Statement”), be accelerated so
that the Registration Statement will become effective at 9:00 a.m., New York City time, on October 15, 2008, or as soon thereafter as may be practicable.
The Registrant hereby acknowledges that:
•
should the Commission or the staff of the Commission (the “Staff”), acting
pursuant to delegated authority, declare the Registration Statement effective, it
does not foreclose the Commission from taking any action with respect to the
Registration Statement;
•
the action of the Commission or the Staff, acting pursuant to delegated
authority, in declaring the Registration Statement effective, does not relieve the
Registrant from its full responsibility for the adequacy and accuracy of the
disclosure in the Registration Statement; and
•
the Registrant may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Securities and Exchange Commission
October 14, 2008
Page Two
Very truly yours,
Teva Pharmaceutical Industries Limited
By:
/s/ Eyal Desheh
Name:
Eyal Desheh
Title:
C.F.O.